The HemOnc Pulse cover image

What Are the Top Questions in ALL?

The HemOnc Pulse

00:00

Treatment Options for Relapse Disease in ALL

The chapter discusses the current treatment options for relapsed disease in acute lymphoblastic leukemia (ALL), including CAR-T therapy, allogeneic transplant, and newer drugs and novel therapies targeting CD-19, CD-22, CD-20, and BCL-2 inhibitors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app